Neurologists Update Criteria to Accelerate MS Diagnosis
The McDonald Diagnostic Criteria for multiple sclerosis (MS), the guidelines used by healthcare professionals worldwide to diagnose the…
Genetic Testing Enables Tailored Treatments, Better Outcomes
Q: What solutions does OncoAtlas bring to patients and health professionals? A: OncoAtlas is a science-based company that…
ADHD Meds Offer Benefits Far Beyond Core Symptom Relief
Attention-deficit/hyperactivity disorder (ADHD) medications appeared to reduce the risk for suicide, drug misuse, transport incidents, and criminal activity,…
MHRA Approves UK’s First Nasal Spray for Anaphylaxis
An adrenaline nasal spray for the emergency treatment of anaphylaxis has been approved by the Medicines and Healthcare…
Is the Supplement Ready for Clinical Use?
Popular among bodybuilders, creatine supplementation is gaining traction for its potential use beyond athletic performance. Researchers are exploring…
First New PTSD Drug in Two Decades On the Horizon?
The Psychopharmacologic Drugs Advisory Committee of the FDA is set to meet on July 18 to consider a…